Recent data and statistics demonstrate that overall American life expectancy has dropped for the first time in a decade, spurring an urgent and pressing need for the advent and proliferation of medical technology—coupled with scientific progress and laws to encourage innovation.
While the research points to specific factors that have lowered rates of mortality, including increased obesity, long-term unemployment, and a resurgence of chronic diseases, the studies incontrovertibly suggest the critical need to provide enhanced ‘life-saving and life-prolonging’ therapies and treatments.
There is no specific way to address the divergence of issues regarding lowered life expectancy, but there are particular measures that must be undertaken. These include enacting evidence-based policies that spur innovation, and further eliminating any roadblocks to America’s inventors.
By spearheading research that targets the most grave and life-threatening challenges in our medical and healthcare system, new resources will grow and develop, ultimately allowing for patients to access breakthrough therapies. The need for medical-technology innovation is steadily increasing, while removing obstacles to improving patient outcomes and creating high-tech manufacturing jobs remains a challenge.
We must collectively and cooperatively tackle the persistent healthcare problems that our country faces, while boosting innovation in the technological sector in order to further address medical challenges.